Business
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
Builds Support for Accelerated Access to SkinJect® for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced that CEO Dr. Raza Bokhari, along with the Medicus leadership team, conducted a series of meetings on Capitol
About this update from Medicus Pharma Ltd.
[{"type":"image","alt":"Medicus Pharma Ltd","displaySize":"","headline":null,"caption":"Medicus Pharma Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/536b378d21fd9e670e64143c1efe36b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/uoifKLnfqp3oBT8AqCcLTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0Nw--/https://media.zenfs.com/en/globenewswire.com/536b378d21fd9e670e64143c1efe36b1","width":300,"height":105}},"lazy":false},{"type":"text","content":"Builds Support for Accelerated Access to SkinJect® for Gorlin Syndrome patients with a Rare Autosomal Dominant Disease","length":118,"tagName":"p"},{"type":"text","content":"PHILADELPHIA, April 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, today announced that CEO Dr. Raza Bokhari, along with the Medicus leadership team, conducted a series of meetings on Capitol Hill with senior lawmakers across key healthcare committees to advance support for:","length":491,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Orphan Drug Designation for SkinJect® for Gorlin Syndrome","length":57,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Registrational Investigation New Drug (IND) approval for Gorlin Syndrome patients","length":81,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Rare disease pediatric FDA voucher program","length":42,"tagName":"p","attribs":{}}]}],"tagName":"ol","bulletedList":false,"length":180},{"type":"text","content":"These engagements included:","length":27,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Brett Guthrie — Chair of the House Energy & Commerce Committee, which has primary jurisdiction over U.S. healthcare policy","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"John Joyce — Member, House Energy & Commerce Committee; Co-Chair, CongressionalSkin Cancer Caucus","length":106,"tagName":"p"}]},{"val":[{"type":"text","content":"Diana Harshbarger — Vice Chair, House Energy & Commerce Subcommittee on Health","length":87,"tagName":"p"}]},{"val":[{"type":"text","content":"Gus B...